KATELYN HOOD: Open Payments
NPI 1700552015 · DECATUR, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,292 in 43 payments from 10 companies in 2025. Trend: 2023 $278 · 2024 $603 · 2025 $1,292
Food & beverage: $1,292
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $473 |
| Ardelyx, Inc. | 7 | $247 |
| Madrigal Pharmaceuticals | 3 | $191 |
| Janssen Biotech, Inc. | 5 | $147 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $61 |
| Gilead Sciences, Inc. | 2 | $51 |
| Ipsen Biopharmaceuticals, Inc | 2 | $47 |
| Phathom Pharmaceuticals, Inc. | 3 | $32 |
| Novo Nordisk Inc | 1 | $23 |
| EVOKE PHARMA, INC. | 1 | $21 |
Products named: LINZESS, IBSRELA, REZDIFFRA, TREMFYA, CREON, ENTYVIO, IQIRVO, VOQUEZNA.
Industry payments across AL — which companies pay providers there.
